R13AG076059
Project Grant
Overview
Grant Description
Risk and Resilience to Alzheimer's Disease in African Americans - Project Summary/Abstract
A national conference on risk and resilience to Alzheimer's Disease in African Americans will take place at Rutgers University-Newark, in Newark, New Jersey, on June 23-24, 2022.
Although African Americans are at elevated risk for age-related cognitive decline and memory loss—with double the prevalence of Alzheimer's Disease (AD) compared to white Americans—we do not sufficiently understand the causes of this health disparity, nor how to best focus future interventional efforts to remediate this health crisis.
This day-and-a-half conference will present the latest data on biological, behavioral, social, and environmental influences on individual differences in aging, brain health, and AD in older African Americans, bridging correlational, longitudinal, and interventional methodologies.
The three related specific aims of the conference are to: (1) promote cross-disciplinary collaboration and communication among researchers who study risk and resilience to AD in African Americans; (2) support trainees and early career investigators in this field; and (3) promote wider scientific, clinical, and public awareness of the factors which affect risk and resilience to AD in African Americans.
Finally, this meeting will be innovative in four ways: (1) it will focus on interdisciplinary approaches to risk and resilience to AD in African Americans; (2) we integrate African American community leaders and research participants in the programming; (3) a planned guest-edited volume of the Journal of Alzheimer's Disease with contributions from the speakers will ensure wide dissemination and impact; (4) as Rutgers-Newark is an urban public university rated #1 in ethnic diversity by US News & World Report, a federally-qualified minority-serving institution, and a NIH G-RISE minority graduate student training center, this meeting will enhance training and career development for undergraduate and graduate students from under-represented minority groups.
A national conference on risk and resilience to Alzheimer's Disease in African Americans will take place at Rutgers University-Newark, in Newark, New Jersey, on June 23-24, 2022.
Although African Americans are at elevated risk for age-related cognitive decline and memory loss—with double the prevalence of Alzheimer's Disease (AD) compared to white Americans—we do not sufficiently understand the causes of this health disparity, nor how to best focus future interventional efforts to remediate this health crisis.
This day-and-a-half conference will present the latest data on biological, behavioral, social, and environmental influences on individual differences in aging, brain health, and AD in older African Americans, bridging correlational, longitudinal, and interventional methodologies.
The three related specific aims of the conference are to: (1) promote cross-disciplinary collaboration and communication among researchers who study risk and resilience to AD in African Americans; (2) support trainees and early career investigators in this field; and (3) promote wider scientific, clinical, and public awareness of the factors which affect risk and resilience to AD in African Americans.
Finally, this meeting will be innovative in four ways: (1) it will focus on interdisciplinary approaches to risk and resilience to AD in African Americans; (2) we integrate African American community leaders and research participants in the programming; (3) a planned guest-edited volume of the Journal of Alzheimer's Disease with contributions from the speakers will ensure wide dissemination and impact; (4) as Rutgers-Newark is an urban public university rated #1 in ethnic diversity by US News & World Report, a federally-qualified minority-serving institution, and a NIH G-RISE minority graduate student training center, this meeting will enhance training and career development for undergraduate and graduate students from under-represented minority groups.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Newark,
New Jersey
071021808
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 01/31/23 to 01/31/24 and the total obligations have decreased 1% from $49,991 to $49,407.
The State University Of New Jersey Rutgers was awarded
Project Grant R13AG076059
worth $49,407
from National Institute on Aging in February 2022 with work to be completed primarily in Newark New Jersey United States.
The grant
has a duration of 2 years and
was awarded through assistance program 93.866 Aging Research.
The Project Grant was awarded through grant opportunity NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed).
Status
(Complete)
Last Modified 5/20/24
Period of Performance
2/1/22
Start Date
1/31/24
End Date
Funding Split
$49.4K
Federal Obligation
$0.0
Non-Federal Obligation
$49.4K
Total Obligated
Activity Timeline
Transaction History
Modifications to R13AG076059
Additional Detail
Award ID FAIN
R13AG076059
SAI Number
R13AG076059-3031949562
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NN00 NIH NATIONAL INSITUTE ON AGING
Funding Office
75NN00 NIH NATIONAL INSITUTE ON AGING
Awardee UEI
T3NGNR66YK89
Awardee CAGE
4CPZ9
Performance District
NJ-10
Senators
Robert Menendez
Cory Booker
Cory Booker
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute on Aging, National Institutes of Health, Health and Human Services (075-0843) | Health research and training | Grants, subsidies, and contributions (41.0) | $49,991 | 100% |
Modified: 5/20/24